Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
5.58
+0.33 (6.19%)
Sep 2, 2026, 12:04 PM EDT - Market open
Embecta Market Cap
Embecta has a market cap or net worth of $315.88 million as of September 2, 2026. Its market cap has decreased by -62.70% in one year.
Market Cap
315.88M
Enterprise Value
1.60B
1-Year Change
-62.70%
Ranking
Category
Stock Price
$5.58
ChartMarket Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $315.88M, a decrease of -88.20%. That is a compound annual growth rate of -38.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 291.23M | -58.60% |
| Dec 31, 2025 | 703.44M | -41.40% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 851.79M |
| AngioDynamics | 655.12M |
| Anbio Biotechnology | 336.65M |
| Sanara MedTech | 317.63M |
| OraSure Technologies | 248.29M |
| Utah Medical Products | 231.69M |
| Pro-Dex | 199.72M |
| Jin Medical International | 183.53M |